Sentara:

Sensyne Health and Sentara Healthcare Form New Partnership for Ethical Data Sharing and Design of New Clinical Algorithms

Retrieved on: 
Thursday, August 19, 2021
Research, Technology, Security, Cardiology, Software, Biotechnology, General Health, Health, Data Management, Science, HIPAA, Legislation, SENS, LSE, Data, Research, Foundation for Strategic Research, Disease, SRA, Health, Outline of health sciences, Forbes, Health Insurance Portability and Accountability Act, AI, Hospital, Consistency, CKD, Safety, CHF, Patient, Partnership, Algorithm, IBM, Health equity, Accountability Act, Watson (computer), Pharmaceutical industry, Medical device, Management, Medicine, Medical imaging, Sensyne Health, Sentara:, SENSYNE HEALTH, SENTARA:

Sentara will join 11 UK NHS Trusts and U.S. Health Systems who are partners and shareholders in Sensyne Health.

Key Points: 
  • Sentara will join 11 UK NHS Trusts and U.S. Health Systems who are partners and shareholders in Sensyne Health.
  • The partnership combines both life sciences research and healthcare algorithm development that will deliver value back to Sentara and its patients.
  • The agreement will enable the ethical application of clinical AI research by Sensyne through analyzing Sentaras patient dataset to improve patient care and accelerate medical research.
  • The Sensyne partnership has the potential to help our organization continue our mission of improving health every day in critical areas of healthcare, including health equity."